Skip Navigation Links

Project Information

OPTIMIZING LUPUS MANAGEMENT IN PREGNANCY

Agency:
AHRQ

HHS/Agency for Healthcare Research and Quality

Project Number:
1K18HS023443-01A1
Contact PI / Project Leader:
CLOWSE, MEGAN E.B.
Awardee Organization:
DUKE UNIVERSITY

Description

Abstract Text:
 DESCRIPTION (provided by applicant): Over half of pregnancies in women with lupus are complicated by miscarriage, preterm birth, or preeclampsia, most commonly in women with significant lupus activity. The guiding principle of lupus management is thus to use the safest available medications to prevent flares during pregnancy. Data supporting this principle are scarce, however, and based on small cohorts. Limitations in the data have also prevented identification of the best treatment strategies for women with varying risks. The goal of this proposal is to identify strategies that optimize pregnancy outcomes using comparative effectiveness approaches. The first method will be a patient- level meta-analysis based on datasets from published lupus pregnancy cohorts; 8 of the largest cohorts have already demonstrated interest. By stratifying pregnancies by lupus activity, prior renal disease, and maternal race, this analysis will yield new data about optimal medication therapies to control lupus and improve pregnancy outcomes. The second method, a decision analysis, will assess potential cost and pregnancy benefits of optimal lupus management. These two aims will offer new data to guide lupus management. Integrating this knowledge into daily practice, however, will be a challenge. For example, current best practices, like continuing hydroxychloroquine (HCQ) in lupus pregnancy, have not yet moved from expert clinics to daily practice. An exploratory aim will use mixed methods to ask community rheumatologists to identify strategies and tools that would enable them to integrate expert recommendations into daily practice. An essential goal is to develop an active Patient Advisory Council (PAC), comprising primarily mothers with lupus, to guide Dr. Clowse in these and future projects. This PAC will be integrated into many aspects of this proposal. Dr. Clowse, a national leader in clinical management of rheumatologic disease in pregnancy, seeks to build new methodology skills to move her research forward. To this end, this proposal outlines a program of research projects, apprenticeships, mentoring, and course work in statistics, comparative effectiveness, and patient-centered outcomes methods. With the primary mentorship of Gillian Sanders-Schmidler, PhD, Director of Duke University's AHRQ-funded Evidence-Based Practice Center, Dr. Clowse will build strong meta- analysis skills. She will practice decision analysis with co-mentor Evan Myers, MD, MPH, lead author for numerous women's health decision analyses and guidelines for AHRQ. At project completion, Dr. Clowse will have the skills, the data, and the stakeholder partnerships needed to drive innovation in the management of lupus in pregnancy.
Project Terms:
base; Clinic; Clinical Management; cohort; Communities; comparative effectiveness; cost; Data; Data Set; Decision Analysis; Disease; Doctor of Philosophy; Evidence based practice; Flare; Funding; Future; Goals; Guidelines; Hydroxychloroquine; improved; innovation; interest; Kidney Diseases; Knowledge; Lead; Lupus; Mentors; Mentorship; Meta-Analysis; Methodology; Methods; Mothers; Patient-Focused Outcomes; Patients; Pharmaceutical Preparations; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Premature Birth; prevent; Program Research Project Grants; Publishing; Race; Recommendation; Research; rheumatologist; Risk; skills; Spontaneous abortion; statistics; tool; treatment strategy; United States Agency for Healthcare Research and Quality; Universities; Woman; Women's Health; Work

Details

Contact PI / Project Leader Information:
Name:  CLOWSE, MEGAN E.B.
Other PI Information:
Not Applicable
Awardee Organization:
Name:  DUKE UNIVERSITY
City:  DURHAM    
Country:  UNITED STATES
Congressional District:
State Code:  NC
District:  01
Other Information:
Fiscal Year: 2015
Award Notice Date: 27-Aug-2015
DUNS Number: 044387793
Project Start Date: 30-Sep-2015
Budget Start Date: 30-Sep-2015
CFDA Code: 226
Project End Date: 29-Sep-2017
Budget End Date: 29-Sep-2016
Agency: ?

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

HHS/Agency for Healthcare Research and Quality
Project Funding Information for 2015:
Year Agency

Agency: The entity responsible for the administering of a research grant, project, or contract. This may represent a federal department, agency, or sub-agency (institute or center). Details on agencies in Federal RePORTER can be found in the FAQ page.

FY Total Cost
2015 AHRQ

HHS/Agency for Healthcare Research and Quality

$212,683

Results

i

It is important to recognize, and consider in any interpretation of Federal RePORTER data, that the publication and patent information cannot be associated with any particular year of a research project. The lag between research being conducted and the availability of its results in a publication or patent award varies substantially. For that reason, it's difficult, if not impossible, to associate a publication or patent with any specific year of the project. Likewise, it is not possible to associate a publication or patent with any particular supplement to a research project or a particular subproject of a multi-project grant.

ABOUT FEDERAL REPORTER RESULTS

Publications: i

Click on the column header to sort the results

PubMed = PubMed PubMed Central = PubMed Central Google Scholar = Google Scholar

Patents: i

Click on the column header to sort the results

Similar Projects

Download Adobe Acrobat Reader:Adobe Acrobat VERSION: 3.41.0 Release Notes
Back to Top